MONEY (MSM)

Drugmaker Valeant raises detailed defense

Valeant’s shares were up about 1 percent in New York and Toronto after tumbling as much as 14 percent before normal trading hours. Laval, Quebec-based Valeant said it has asked U.S. securities regulators to investigate Citron’s “completely untrue” allegation that the company used its ties with a specialty pharmacy to inflate revenue, and said it would conduct a review of its pharmacy network. About a dozen executives, a former chief

Drugmaker Valeant raises detailed defense

Valeant’s shares were up about 1 percent in New York and Toronto after tumbling as much as 14 percent before normal trading hours. Laval, Quebec-based Valeant said it has asked U.S. securities regulators to investigate Citron’s “completely untrue” allegation that the company used its ties with a specialty pharmacy to inflate revenue, and said it would conduct a review of its pharmacy network. About a dozen executives, a former chief